Related Experiment Video
Updated: Mar 1, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
13.0K
[HORMONE REPLACEMENT THERAPY AFTER GYNECOLOGICAL MALIGNANCIES].
1Obstetrics and Gynecology, Gynecological Oncology Unit, Lis Maternity Hospital Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University.
Harefuah
|May 29, 2017
Summary
Hormone replacement therapy (HRT) is effective for menopausal symptoms after gynecologic cancer treatment. Current evidence suggests HRT does not increase cancer recurrence risk, supporting individualized patient discussions.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
Background:
- Gynecologic cancer treatments often induce premature menopause, causing significant morbidity.
- Hormone replacement therapy (HRT) is the most effective symptom management but its safety in cancer patients is debated.
Purpose of the Study:
- To review existing literature on the risk of disease recurrence in gynecologic cancer patients using HRT.
- To assess the safety and efficacy of HRT in this patient population.
Main Methods:
- Systematic review of published literature, focusing on cohort studies.
- Analysis of evidence regarding HRT use and recurrence risk for various gynecologic malignancies.
Main Results:
- Limited prospective trials exist.
- Current evidence does not show increased recurrence risk for endometrial, ovarian epithelial, vulvar, or cervical cancers with HRT use.
- Most gynecologic cancers are presumed hormone-independent.
Conclusions:
- No clear contraindication for HRT in gynecologic cancer patients based on current literature.
- Treatment decisions regarding HRT should be individualized.
- Open discussion of HRT's benefits and risks with patients is essential due to limited high-quality evidence.
More Related Videos
Related Concept Videos
01:28Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
01:22Hormonal Regulation of the Menstrual Cycle
1.9K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.9K
01:24Disorders of the Female Reproductive System
4.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.7K
01:24Gonadal and Placental Hormones
3.5K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.5K
01:30Hormonal Control of the Ovarian Cycle
7.2K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.2K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K